Novavax to Host Conference Call to Discuss Second Quarter 2022 Financial Results and Operational Highlights on August 8, 2022PRNewsWire • 08/01/22
Novavax Announces Expanded Approval of Nuvaxovid™ COVID-19 Vaccine for Adolescents Aged 12 through 17 in JapanPRNewsWire • 07/26/22
Novavax Nuvaxovid™ COVID-19 Vaccine Granted Provisional Registration in Australia for Use in Adolescents Aged 12 Through 17PRNewsWire • 07/26/22
Novavax Wins FDA OK For Covid Shot, But Collapses — Is It A Buy Or A Sell?Investors Business Daily • 07/22/22
CDC OK's Novavax vaccine to add fifth shot to U.S. program, and COVID cases triple in Europe in six-week spanMarket Watch • 07/20/22
CDC gives final approval for more traditional Novavax COVID vaccine for adultsMarket Watch • 07/19/22
U.S. CDC Advisory Committee Unanimously Recommends Novavax COVID-19 Vaccine, Adjuvanted as a Primary Series for Individuals Aged 18 and OlderPRNewsWire • 07/19/22